Recent News

• 06.09.2025 - Bio-Path Holdings to Present at Life Sciences Virtual Investor Forum
• 06.03.2025 - Bio-Path Holdings Provides Clinical and Operational Update
• 05.22.2025 - Bio-Path Holdings to Host Corporate Update Conference Call on May 29, 2025
• 05.01.2025 - Bio-Path Holdings Achieves Third Pre-Clinical Milestone Confirming Potential of BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
• 03.28.2025 - Bio-Path Holdings Reports Full Year 2024 Financial Results

Recent Filings

• 06.02.2025 - 253G3 253G3
• 05.29.2025 - QUALIF Notice of Qualification [Regulation A]
• 05.16.2025 - 1-A/A Offering Statement [Regulation A]
• 05.15.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.02.2025 - EX-99.1 EX-99.1
• 05.02.2025 - 8-K Current report
• 04.29.2025 - 8-K Current report
• 04.11.2025 - 1-A Offering Statement [Regulation A]
• 04.09.2025 - RW Registration Withdrawal Request